PMC6681596_01
Abdominal striae.
CRIE2019-1989260.001.jpg
PMC6681596_01_CRIE2019-1989260.001.jpg
fig1
Her abdomen was distended, nontender, with thick purple striae (Figure 1).
Chest X-Ray showing 2 left upper lobe lung masses.
CRIE2019-1989260.002.jpg
PMC6681596_01_CRIE2019-1989260.002.jpg
fig2
Given our high clinical suspicion for EAS, we performed a chest x-ray, which identified two left upper lobe lung masses (Figure 2).
Neuroendocrine lung tumor biopsy staining positive for synaptophysin.
CRIE2019-1989260.003.jpg
PMC6681596_01_CRIE2019-1989260.003.jpg
fig3
A computed tomography (CT) guided lung biopsy confirmed well-differentiated NET (Figure 3).
Commuted tomography showing 2 left upper lobe lung masses.
CRIE2019-1989260.004.jpg
PMC6681596_01_CRIE2019-1989260.004.jpg
fig4
The lung biopsy stained positive for synaptophysin, chromogranin, and pancytokeratin (Figure 4).
Neuroendocrine lung tumor biopsy with <2% Ki-67 proliferation index.
CRIE2019-1989260.005.jpg
PMC6681596_01_CRIE2019-1989260.005.jpg
fig5
The Ki-67 proliferation index was low <2% (Figure 5).
Positron emission tomography/commuted tomography showing 2 left upper lobe lung masses.
CRIE2019-1989260.006.jpg
PMC6681596_01_CRIE2019-1989260.006.jpg
fig6
Positron emission tomography showed hypermetabolic activity within the lung masses, left hilum, and mediastinal lymph nodes (Figure 6).
Surgical specimen of one of the resected lung masses.
CRIE2019-1989260.007.jpg
PMC6681596_01_CRIE2019-1989260.007.jpg
fig7
She underwent wedge resection of her left upper lobe and was treated with a steroid taper perioperatively (Figure 7).